BET inhibitor JQ1 enhances anti-tumor immunity and synergizes with PD-1 blockade in CRC

Most colorectal cancer (CRC) patients are insensitive to immune checkpoint inhibitors (ICIs) due to the immunosuppressive tumor microenvironment (TME). Epigenetic factors such as the bromo-and extraterminal domain (BET) family proteins may be responsible for the immunosuppressive microenvironment. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huijin, Liu, Guangyao, Jin, Xinghan, Song, Shenglei, Chen, Songyao, Zhou, Peiqing, Li, Huan, Liang, Jianming, Li, Bo, Zhang, Changhua, He, Yulong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066214/
https://www.ncbi.nlm.nih.gov/pubmed/35517410
http://dx.doi.org/10.7150/jca.69375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066214/
https://www.ncbi.nlm.nih.gov/pubmed/35517410
http://dx.doi.org/10.7150/jca.69375

Ejemplares similares